کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3975391 1600978 2014 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
پیش نمایش صفحه اول مقاله
Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
چکیده انگلیسی

ObjectiveGonadotropin-releasing hormone (GnRH) receptor is found in the ovarian tissue, including epithelial ovarian cancer (EOC), suggesting that GnRH agonists may have direct action on EOC.Materials and methodsOvarian clear cell cancer (ES-2) cells were treated with low-dose GnRH agonist with/without low-dose paclitaxel (1 μM D-Lys6 with/without 0.5 μM or 1.0 μM paclitaxel). Growth and behavior of ES-2 cells were evaluated.ResultsUse of either D-Lys6 or paclitaxel or a combination of the two did not affect the morphology and growth pattern of ES-2 cells. However, ability of migration and invasion of ES-2 cells was significantly decreased in either use of D-Lys6 or paclitaxel and more apparent with the combination. Type I GnRH receptor expression of ES-2 was not altered significantly by the combination.ConclusionGnRH agonist might modify the ES-2 ovarian cancer cells, and its role might be independent, additional or synergistic, suggesting the potential role of the use of GnRH agonist in the management of clear cell type of the ovarian cancer. However, the results of this study were derived using ES-2 ovarian cancer cells, and might not be valid in other cell types of ovarian cancers.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Taiwanese Journal of Obstetrics and Gynecology - Volume 53, Issue 1, March 2014, Pages 35–42
نویسندگان
, , , , , , , , , ,